Chinese patent medicine for osteoporosis: a systematic review and meta-analysis

Chinese patent medicine (CPM) has been widely used in China for patients with osteoporosis (OP) but a comprehensive literature review is still important. Therefore, we performed meta-analysis using six electronic databases prior to 30 April 2021 only randomized controlled trials (RCTs) using CPM as...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Yan, Sun, Jigao, Zhao, Yan, Tang, Kaiqiang, Zhu, Ruizheng, Zhao, Wei, Wang, Rongtian, Zhang, Yanqiong, Lin, Na, Chen, Weiheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973707/
https://www.ncbi.nlm.nih.gov/pubmed/35184684
http://dx.doi.org/10.1080/21655979.2022.2038941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973707/
https://www.ncbi.nlm.nih.gov/pubmed/35184684
http://dx.doi.org/10.1080/21655979.2022.2038941

Ejemplares similares